ADARTREL, known generically as ropinirole, is a medication primarily used in the treatment of Parkinson's disease and restless legs syndrome (RLS). It belongs to a class of drugs known as dopamine agonists, which work by mimicking the action of dopamine, a neurotransmitter in the brain that is involved in controlling movement and coordination. In patients with Parkinson's disease, dopamine levels are low, leading to the characteristic symptoms of the condition. By stimulating dopamine receptors, ADARTREL helps to improve these symptoms. For those with restless legs syndrome, ADARTREL can reduce the discomfort and urge to move the legs that typically interfere with sleep. It is available in tablet form and is usually taken once daily, with or without food, as directed by a healthcare provider. When using ADARTREL, it's crucial to take certain precautions to ensure your safety and the effectiveness of the medication. ADARTREL can cause side effects that may impair your ability to drive or operate machinery safely, such as dizziness or drowsiness. Common side effects include nausea, headache, and fatigue, while rare side effects can be more severe, including hallucinations or allergic reactions. It's of utmost importance to follow your doctor's instructions closely and to read the label that comes with the medicine thoroughly. Always inform your doctor about any other medications you are taking to avoid potential interactions. Adhering to these guidelines will help minimize risks and maximize the benefits of using ADARTREL.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.